Syndax Pharmaceuticals SNDX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's quick ratio?
- Syndax Pharmaceuticals (SNDX) reported quick ratio of 5.1× in Q1 2026.
- How has Syndax Pharmaceuticals's quick ratio changed year-over-year?
- Syndax Pharmaceuticals's quick ratio decreased by 12.0% year-over-year, from 5.8× to 5.1×.
- What is the long-term trend for Syndax Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's quick ratio has grown at a -23.6% compound annual growth rate (CAGR), from 15.8× to 4.1×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.